Biotech

All Articles

A deeper consider Strong Biotech's Ferocious 15

.Within this full week's episode of "The Best Pipe," our company're diving right into Intense Biotec...

Lilly encounters stage 2 breakdown of tau-targeting med

.The confetti is actually still flying from Eli Lilly's party celebrating the approval of Alzheimer'...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of significant management hirings, shootings ...

Lykos are going to ask FDA to rethink its selection following rejection of MDMA therapy for post-traumatic stress disorder

.Following an inadequate revealing for Lykos Rehabs' MDMA applicant for trauma at a recent FDA advis...

AN 2 fifty percents head count, stops period 3 test after information disappoint

.AN2 Therapeutics is rethinking its organization in feedback to lackluster midphase data, swearing t...

Merck spends $700M for bispecific, spying autoimmune position as well as chance to challenge Amgen in cancer cells

.Merck &amp Co. is actually paying for $700 thousand ahead of time to challenge Amgen in a blood can...

Gilead pays out J&ampJ $320M to go out licensing deal for seladelpar

.Along With Gilead Sciences about to an FDA choice for its liver illness medication seladelpar, the ...

' All hands on deck' at Lilly as peers target weight problems market

.CEO David Ricks may find the companies establishing outdoors tents at basecamp responsible for Eli ...

Entero giving up staff, abandoning office and also pausing R&ampD

.Mattress Liquidators has actually transformed Entero Rehabs white colored as a slab. The collector ...

Exelixis drops ADC after choosing it's no suit for Tivdak

.Exelixis is actually losing hope on its own tissue aspect (TF)- targeting antibody-drug conjugate a...